Published in Psychopharmacologia on January 01, 1971
Mood changes associated with "end-of-dose deterioration" in Parkinson's disease: a controlled study. J Neurol Neurosurg Psychiatry (1986) 0.88
5-hydroxytryptamine and depression: a model for the interaction of normal variance with pathology. Br J Clin Pharmacol (1983) 0.83
Apomorphine and psychopathology. J Neurol Neurosurg Psychiatry (1975) 0.80
Dopamine correlates of neurological and psychological status in untreated Parkinsonism. J Neurol Neurosurg Psychiatry (1976) 0.76
Controlled study comparing nomifensine and clomipramine in unipolar depression, using the probenecid technique. Br J Clin Pharmacol (1977) 0.75
High cholesterol levels in patients with panic disorder. Am J Psychiatry (1992) 2.25
PET visualization of microglia in multiple sclerosis patients using [11C]PK11195. Eur J Neurol (2003) 1.59
Interrelationships among anxiety, aggression, impulsivity, and mood: a serotonergically linked cluster? Psychiatry Res (1990) 1.59
Convergent genetic modulation of the endocrine stress response involves polymorphic variations of 5-HTT, COMT and MAOA. Mol Psychiatry (2007) 1.43
[Depression following a first heart infarct; similarities with and differences from 'ordinary' depression]. Ned Tijdschr Geneeskd (1997) 1.43
Headache and cortisol responses to m-chlorophenylpiperazine are highly correlated. Cephalalgia (1993) 1.41
Fluorimetric determination of 5-hydroxyindoleacetic acid in human urine and cerebrospinal fluid. Clin Chim Acta (1969) 1.40
[Mania: clinical aspects, cause and treatment]. Ned Tijdschr Geneeskd (1994) 1.40
Dissociable hormonal, cognitive and mood responses to neuroendocrine challenge: evidence for receptor-specific serotonergic dysregulation in depressed mood. Neuropsychopharmacology (2002) 1.40
beta-amyloid neurotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalis. Eur J Neurosci (2000) 1.25
Plasma concentrations of diazepam and of its metabolite N-desmethyldiazepam in relation to anxiolytic effect. Clin Pharmacol Ther (1974) 1.23
Effect of intravenously administered probenecid in humans on the levels of 5-hydroxyindoleacetic acid, homovanillic acid and 3-methoxy-4-hydroxy-phenylglycol in cerebrospinal fluid. Biochem Pharmacol (1971) 1.23
Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation. Psychopharmacology (Berl) (1999) 1.22
Noradrenergic neurons: morphine inhibition of spontaneous activity. Eur J Pharmacol (1974) 1.21
Amitriptyline plasma-concentration and clinical effect. A World Health Organisation Collaborative Study. Lancet (1978) 1.19
Is there a relation between the seriousness of suicidal intent and the lethality of the suicide attempt? Psychiatry Res (1989) 1.18
Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study. Mult Scler (2005) 1.17
One brain, two selves. Neuroimage (2003) 1.14
Exposure to chronic psychosocial stress and corticosterone in the rat: effects on spatial discrimination learning and hippocampal protein kinase Cgamma immunoreactivity. Hippocampus (1997) 1.14
Amine metabolism in the human brain: further evaluation of the probenecid test. Brain Res (1971) 1.09
Fluvoxamine and clomipramine in depressed patients. A double-blind clinical study. Acta Psychiatr Scand (1981) 1.05
Anxiety, impulsivity and depressed mood in relation to suicidal and violent behavior. Acta Psychiatr Scand (1993) 1.05
A self-report measure of violence risk, II. Compr Psychiatry (1990) 1.04
The peripheral GABAergic system as a target in endocrine disorders. Auton Neurosci (2005) 1.04
Interconvertability of five self-report measures of depression. Psychiatry Res (1987) 1.04
Increased turnover of norepinephrine in the rat cerebral cortex during stress: role of the locus coeruleus. Neuropharmacology (1973) 1.02
Migraine and function of the immune system: a meta-analysis of clinical literature published between 1966 and 1999. Cephalalgia (2001) 1.01
The role of serotonin in schizophrenia. Schizophr Bull (1988) 1.00
On the significance of regional dopamine metabolism in the rat brain for the classification of centrally acting drugs. Eur J Pharmacol (1977) 1.00
Significance of cocaine history in schizophrenia. J Nerv Ment Dis (1990) 0.99
Influence of drugs on striatal and limbic homovanillic acid concentration in the rat brain. Eur J Pharmacol (1975) 0.99
Cerebral monoamines and depression. An investigation with the Probenecid technique. Arch Gen Psychiatry (1973) 0.99
Neuroanatomy of cardiac activity-regulating circuitry: a transneuronal retrograde viral labelling study in the rat. Eur J Neurosci (1996) 0.99
5-Hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid. Nature (1970) 0.98
Management of depression with serotonin precursors. Biol Psychiatry (1981) 0.97
Dopamine release in substantia nigra? Nature (1976) 0.97
Correlates of suicide and violence risk: III. A two-stage model of countervailing forces. Psychiatry Res (1989) 0.96
Effects of stress and exercise on rat hippocampus and striatum extracellular lactate. Am J Physiol (1990) 0.96
Depression. Lancet (1982) 0.94
Neurone-specific enolase and N-acetyl-aspartate as potential peripheral markers of ischaemic stroke. Eur J Clin Invest (1999) 0.93
Cyclic AMP in cerebrospinal fluid: accumulaiton following probenecid and biogenic amines. Exp Neurol (1975) 0.93
Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens. Brain Res (1991) 0.92
Mood effects of 24-hour tryptophan depletion in healthy first-degree relatives of patients with affective disorders. Biol Psychiatry (1999) 0.91
Regional rat brain levels of 3,4-dihydroxyphenylacetic acid and homovanillic acid: concurrent fluorometric measurement and influence of drugs. Eur J Pharmacol (1976) 0.91
Neurobiology and neuroimmunology of Tourette's syndrome: an update. Cell Mol Life Sci (2004) 0.91
Metyrapone reduces rat brain damage and seizures after hypoxia-ischemia: an effect independent of modulation of plasma corticosterone levels? J Cereb Blood Flow Metab (1998) 0.91
Manganese-induced hydroxyl radical formation in rat striatum is not attenuated by dopamine depletion or iron chelation in vivo. Exp Neurol (1996) 0.91
Trigeminal nociception-induced cerebral Fos expression in the conscious rat. Cephalalgia (2001) 0.90
Fluorometric determination of homovanillic acid in biological material after isolation on Sephadex G-10. Anal Biochem (1971) 0.90
Relative changes in regional cerebral blood flow during spinal cord stimulation in patients with refractory angina pectoris. Eur J Neurosci (1997) 0.89
The clinical significance of halopemide, a dopamine-blocker related to the butyrophenones. Neuropsychobiology (1984) 0.89
In vivo identification and quantitative evaluation of carrier-mediated transport of lactate at the cellular level in the striatum of conscious, freely moving rats. J Cereb Blood Flow Metab (1988) 0.89
Regional levels of GABA in the brain: rapid semiautomated assay and prevention of postmortem increase by 3-mercapto-propionic acid. J Neurochem (1978) 0.89
The role of serotonin in schizophrenia. Eur Neuropsychopharmacol (1995) 0.88
The corticosterone synthesis inhibitor metyrapone prevents hypoxia/ischemia-induced loss of synaptic function in the rat hippocampus. Stroke (2000) 0.88
Interruptions of early cortical development affect limbic association areas and social behaviour in rats; possible relevance for neurodevelopmental disorders. Brain Res (1999) 0.88
Desmethylimipramine enhances the release of endogenous GABA and other neurotransmitter amino acids from the rat thalamus. J Neurochem (1983) 0.88
Cobalt-55 positron emission tomography of ipsilateral thalamic and crossed cerebellar hypometabolism after supratentorial ischaemic stroke. Cerebrovasc Dis (1999) 0.87
In vivo binding of N-n-propylnorapomorphine in the rat brain: regional localization, quantification in striatum and lack of correlation with dopamine metabolism. Eur J Pharmacol (1983) 0.87
Impaired sensory gating and attention in rats with developmental abnormalities of the mesocortex. Implications for schizophrenia. Ann N Y Acad Sci (2000) 0.87
[Predictive value of the probenecid test for the effect of L-DOPA therapy in Parkinson's disease]. Nat New Biol (1972) 0.86
Altered synaptic plasticity in hippocampal CA1 area of apolipoprotein E deficient mice. Neuroreport (1997) 0.86
The therapeutic effect of short-term oral diazepam treatment on acute clinical anxiety in a crisis centre. Acta Psychiatr Scand (1974) 0.86
Treatment of depression in Parkinson's disease: a meta-analysis. J Neuropsychiatry Clin Neurosci (1995) 0.86
Wilson's disease and monoamines. Arch Neurol (1978) 0.86
Unique patterns of FOS, phospho-CREB and BrdU immunoreactivity in the female rat brain following chronic stress and citalopram treatment. Neuropharmacology (2005) 0.86
A controlled study of temporal lobe structure volumes and P300 responses in schizophrenic patients with persistent auditory hallucinations. Schizophr Res (1999) 0.86
Specificity of the tryptophan depletion method. Psychopharmacology (Berl) (1999) 0.86
High central D2-dopamine receptor occupancy as assessed with positron emission tomography in medicated but therapy-resistant schizophrenic patients. Biol Psychiatry (1991) 0.85
Serotonin and anxiety revisited. Biol Psychiatry (1988) 0.85
Neuroleptics as a guideline to biological research in psychotic disorders. Compr Psychiatry (1975) 0.85
Selective serotonin reuptake inhibitors (SSRIs) in the treatment of elderly depressed patients: a qualitative analysis of the literature on their efficacy and side-effects. Int Clin Psychopharmacol (1996) 0.85
Cerebral cation shifts in hypoxic-ischemic brain damage are prevented by the sodium channel blocker tetrodotoxin. Exp Neurol (1988) 0.85
Extracellular lactic acid as an indicator of brain metabolism: continuous on-line measurement in conscious, freely moving rats with intrastriatal dialysis. J Cereb Blood Flow Metab (1988) 0.85
Supplementation of a low dose of DHA or DHA+AA does not prevent peripartum depressive symptoms in a small population based sample. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.85
Correlates of suicide and violence risk 1: the suicide risk measure. Compr Psychiatry (1989) 0.84
Kinetics of l-5-hydroxytryptophan in healthy subjects. Psychiatry Res (1982) 0.84
Correlates of risk of suicide in violent and nonviolent psychiatric patients. Am J Psychiatry (1991) 0.84
Antidepressive effect of mirtazapine in post-myocardial infarction depression is associated with soluble TNF-R1 increase: data from the MIND-IT. Neuropsychobiology (2011) 0.84
A single social stress-experience alters glutamate receptor-binding in rat hippocampal CA3 area. Neurosci Lett (1993) 0.84
Regional calcium accumulation and cation shifts in rat brain by kainate. J Neurochem (1984) 0.84
A pilot study of some kinetic aspects of the metabolism of 5-hydroxytryptamine in depressive patients. Biol Psychiatry (1971) 0.84
Central serotonin metabolism and frequency of depression. Psychiatry Res (1979) 0.84
Different localization of histidine decarboxylase and histamine-N-methyltransferase in the rat brain. Brain Res (1978) 0.83
L-deprenyl reduces brain damage in rats exposed to transient hypoxia-ischemia. Stroke (1995) 0.83
Divergent axon collaterals of rat locus coeruleus neurons: demonstration by a fluorescent double labeling technique. Brain Res (1981) 0.83
Low essential fatty acid and B-vitamin status in a subgroup of patients with schizophrenia and its response to dietary supplementation. Prostaglandins Leukot Essent Fatty Acids (2005) 0.83
Transneuronal viral labelling of rat heart left ventricle controlling pathways. Neuroreport (1993) 0.83
Biochemical evidence for a transmitter role of dopamine in the rat hippocampus. Brain Res (1979) 0.83
Monitoring arterio-venous differences of glucose and lactate in the anesthetized rat with or without brain damage with ultrafiltration and biosensor technology. J Neurosci Res (2001) 0.83
Amino acids in rat striatal dialysates: methodological aspects and changes after electroconvulsive shock. J Neurochem (1985) 0.83
Methylazoxymethanol acetate-induced abnormalities in the entorhinal cortex of the rat; parallels with morphological findings in schizophrenia. Brain Res (1998) 0.83
Dopamine metabolism in depressions, psychoses, and Parkinson's disease: the problem of the specificity of biological variables in behaviour disorders. Psychol Med (1975) 0.83
Serotonin syndrome after challenge with the 5-HT agonist meta-chlorophenylpiperazine. Psychiatry Res (1998) 0.82
Determination of nanogram amounts of homovanillic acid in the central nervous system with a rapid semiautomated fluorometric method. Biochem Med (1975) 0.82